Pharmaceuticals, Biotechnology and Life Sciences
Novartis’ eye care division Alcon has bought a privately-held US medical device company PowerVision, which focuses on focused on creating fluid-based intraocular lens implants, for $285 million at closing with additional payments based on specified regulatory and commercial milestones starting in 2023.
Novartis’s eye care division Alcon, on Tuesday has its first Capital Markets Day for investors and analysts as a tax-neutral,…
Novartis on Friday said it intends to spinoff Alcon, its eye care division, into a separately-traded standalone company, which would…
Novartis’s eye care division Alcon unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ…
Alcon, a division of Novartis, will give 100 reprocessed Infiniti units to eligible clinics in Asia, Central and South America,…
Alcon, a division of Novartis, will introduce Clareon, the intraocular lens (IOL) with the most advanced optic material available in an automated, disposable, pre-loaded delivery system, at the XXXV European Society of Cataract & Refractive Surgeons (ESCRS) congress taking place October 7 – 11 in Lisbon, Portugal.
Alcon, a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens (IOL) with Activefocus optical design for patients undergoing cataract surgery who choose to address their astigmatism and presbyopia at the same time.
Alcon and a division of Novartis have launched AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with pre-existing corneal astigmatism undergoing cataract surgery.
Novartis’ division and eye care specialist Alcon, is introducing its latest advancement in its WaveLightrefractive portfolio Contoura Vision.
Novartis’s Alcon has received US Food and Drug Administration (FDA) approval for its AcrySof IQ Aspheric IOL with the UltraSert Pre-loaded Delivery System for patients undergoing cataract surgery.